Delivery Order SPE2DB20D3505-SPE2DB25FT3A5

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,702,489 units of gabapentin 300 mg capsules. The $1,349.23 firm-fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,091.13 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4564677665 GABAPENTIN 600 MG TABLET 500S, a pharmaceutical product, with a period of performance through May 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,540.77 fixed-price delivery order is for the supply of 4,557,655,972 units of Gabapentin 300 mg capsules. The contract has an ultimate completion date of June 28, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gabapentin 600 mg tablets, a medication used to treat certain types of nerve pain. The contract has a ceiling value of $1,284.80 and is a firm fixed-price delivery order, with a period of performance running through April 11, 2025. There is no set-aside designation for this award....
This federal contract award, valued at $2,814.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a completion date of March 12, 2024, is a Delivery Order for the supply of GABAPENTIN 300 MG CAPSULE 1000S. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,443.41 for the supply of the pharmaceutical product Gabapentin 800 mg tablets. The contract has a period of performance through March 20, 2024 and does not utilize any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,507.38, is a Firm Fixed Price Delivery Order for the supply of Gabapentin 300 mg capsules. The contract has a period of performance through May 28, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 500-count bottles of the prescription medication gabapentin 600 mg tablets, with a total ceiling value of $1,479.13 and a period of performance through April 28, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation,...
This federal contract award is for the delivery of pharmaceutical products, specifically Gabapentin 600 mg tablets, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,166.10 and a completion date of March 2, 2022. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 800 mg gabapentin tablets. The contract has a ceiling value of $2,012.40 and an ultimate completion date of July 26, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network. This contract is part of a larger Indefinite Delivery Contract...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT3A5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,556.03 firm fixed-price delivery order is for the supply of 4,566,181,525 units of Gabapentin 800 mg tablets, with a period of performance through October 23, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, serving as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award did not include any set-aside designations, indicating open competition.

Generated 2/27/25, 12:06 PM